1. | Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, Saliba F, Sauerbruch T, Klammt S, Ockenga J, Pares A, Wendon J, Brünnler T, Kramer L, Mathurin P, de la Mata M, Gasbarrini A, Müllhaupt B, Wilmer A, Laleman W, Eefsen M, Sen S, Zipprich A, Tenorio T, Pavesi M, Schmidt HH, Mitzner S, Williams R, Arroyo V; RELIEF study group.
Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.
Hepatology. 2013 Mar;57(3):1153-62 |
2. | Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, Whittaker S, Tzonev R, Handshiev S, Verslype C, Moench C, Zeuzem S, Sauerbruch T, Guarner C, Schott E, Johnson N, Petrov A, Katzarov K, Nevens F, Zapater P, Such J.
Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study.
J Hepatol. 2013 May;58(5):922-7. doi: 10.1016/j.jhep.2012.12.020. Epub 2013 Jan 11 |
3. | Bennouna J, Sastre J, Arnold D, Osterlund P, Greil R, Van Cutsem E, von Moos R, Viéitez JM, Bouché O, Borg C, Steffens CC, Alonso-Orduña V, Schlichting C, Reyes-Rivera I, Bendahmane B, André T, Kubicka S; on behalf of the ML18147 Study Investigators.
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.
Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. |
4. | Casper M, Kraemer J, Lammert F, Zimmer V.
Protein, o protein: where hast thou gone?
Dig Liver Dis. 2013 Sep;45(9):782. |
5. | Casper M, Weber SN, Kloor M, Müllenbach R, Grobholz R, Lammert F, Zimmer V.
Hepatocellular carcinoma as extracolonic manifestation of Lynch syndrome indicates SEC63 as potential target gene in hepatocarcinogenesis.
Scand J Gastroenterol. 2013 Mar;48(3):344-51. |
6. | Fritz JV, Desai MS, Shah P, Schneider JG, Wilmes P.
From meta-omics to causality: experimental models for human microbiome research.
Microbiome. 2013 May 3;1(1):14. |
7. | Garcia-Pagán JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, Luca A, Zipprich A, Abraldes JG, Nevens F, Vinel JP, Sauerbruch T, Bosch J.
Use of early-TIPS for high-risk variceal bleeding: Results of a post-RCT surveillance study.
J Hepatol. 2013 Jan |
8. | Grotemeyer KC, Zimmer V, Friesenhahn-Ochs B, Lammert F.
Rezidivierende Hypoglykämien mit schwerer neurologischer Symptomatik führten einen 75-Jährigen in die Klinik. Doch was steckte dahinter?.
Internist (Berl). 2013 Jun;54(6):762-4. doi: 10.1007/s00108-013-3278-8. German. |
9. | Grünhage F, Lammert F.
The fate of fatty liver disease: of bile and fatty acids.
Ann Hepatol. 2013 Jul-Aug;12(4):642-3.. |
10. | Hirschfield GM, Chapman RW, Karlsen TH, Lammert F, Lazaridis KN, Mason AL.
The genetics of complex cholestatic disorders.
Gastroenterology. 2013 Jun;144(7):1357-74. |
11. | Hochrath K, Ehnert S, Ackert-Bicknell CL, Lau Y, Schmid A, Krawczyk M, Hengstler JG, Dunn J, Hiththetiya K, Rathkolb B, Micklich K, Hans W, Fuchs H, Gailus-Durner V, Wolf E, de Angelis MH, Dooley S, Paigen B, Wildemann B, Lammert F, Nüssler AK.
Modeling hepatic osteodystrophy in Abcb4 deficient mice.
Bone. 2013 Aug;55(2):501-11. |
12. | Jüngst C, Lammert F, Strassburg CP.
Autoimmun Hepatitis
Dtsch Med Wochenschr. 2013 Dec;138(50):2599-608; quiz 2609-12. |
13. | Jüngst C, Krämer J, Schneider G, Lammert F, Zimmer V.
Subacute liver failure by pseudocirrhotic metastatic breast cancer infiltration.
Ann Hepatol. 2013 Sep-Oct;12(5):834-6. |
14. | Jüngst C, Berg T, Cheng J, Green RM, Jia J, Mason AL, Lammert F.
Intrahepatic cholestasis in common chronic liver diseases.
Eur J Clin Invest. 2013 Oct;43(10):1069-83. |
15. | Jüngst C, Lammert F.
Cholestatic liver disease.
Dig Dis. 2013;31(1):152-4 |
16. | Kaiser R, Grotemeyer K, Kälsch T, Gräber S, Wilkens H, Elmas E.
Decreased TSP-1 following percutaneous coronary intervention is associated with major adverse cardiac events in ST-elevation myocardial infarction.
Clin Hemorheol Microcirc. 2013 Jan 1;54(1):59-73.
Grotemeyer KC, Zimmer V, Friesenhahn-Ochs B, Lammert F.
Internist (Berl). 2013 Jun;54(6):762-4. doi: 10.1007/s00108-013-3278-8. German. |
17. | Kazakov A, Hall R, Jagoda P, Bachelier K, Müller-Best P, Semenov A, Lammert F, Böhm M, Laufs U.
Inhibition of endothelial nitric oxide synthase induces and enhances myocardial fibrosis.
Cardiovasc Res. 2013 Nov 1;100(2):211-21. |
18. | Kessler SM, Pokorny J, Zimmer V, Laggai S, Lammert F, Bohle RM, Kiemer AK.
IGF2 mRNA binding protein p62/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2/PI3K signaling.
Am J Physiol Gastrointest Liver Physiol. 2013 Feb 15;304(4):G328-36. |
19. | Körner R, Preuss KD, Fadle N, Madjidi D, Neumann F, Bergeler L, Gräber S, Müller CS, Grünhage F, Pfreundschuh M, Lammert F, Vogt T, Pföhler C.
Serum antibodies against CD28-- a new potential marker of dismal prognosis in melanoma patients.
PLoS One. 2013;8(3):e58087. |
20. | Krawczyk M, Höblinger A, Mihalache F, Grünhage F, Acalovschi M, Lammert F, Zimmer V.
Macrophage stimulating protein variation enhances the risk of sporadic extrahepatic cholangiocarcinoma.
Dig Liver Dis. 2013 Jul;45(7):612-5. |
21. | Krawczyk M, Portincasa P, Lammert F.
PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease.
Semin Liver Dis. 2013 Nov;33(4):369-79 |
22. | Krawczyk M, Stokes CS, Lammert F.
Genetics and treatment of bile duct stones: new approaches.
Curr Opin Gastroenterol. 2013 May;29(3):329-35 |
23. | Krawczyk M, Miquel JF, Stokes CS, Zuniga S, Hampe J, Mittal B, Lammert F.
Genetics of biliary lithiasis from an ethnic perspective.
Clin Res Hepatol Gastroenterol. 2013 Apr;37(2):119-25. |
24. | Kubicka S, Greil R, André T, Bennouna J, Sastre J, Van Cutsem E, von Moos R, Osterlund P, Reyes-Rivera I, Müller T, Makrutzki M, Arnold D; ML18147 study investigators including AIO, GERCOR, FFCD, UNICANCER GI, TTD, BGDO, GEMCAD, and AGMT groups.
Decreased TSP-1 following percutaneous coronary intervention is associated with major adverse cardiac events in ST-elevation myocardial infarction.Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings.
Ann Oncol. 2013 Sep;24(9):2342-9. |
25. | Liebe R, Hall RA, Williams RW, Dooley S, Lammert F.
Systems genetics of hepatocellular damage in vivo and in vitro: identification of a critical network on chromosome 11 in mouse.
Physiol Genomics. 2013 Oct 16;45(20):931-9. |
26. | Lukacs-Kornek V, Schuppan D.
Dendritic cells in liver injury and fibrosis: shortcomings and promises.
J Hepatol. 2013 Nov;59(5):1124-6. |
27. | Lukacs-Kornek V, Schuppan D.
Dendritic cells in liver injury and fibrosis: shortcomings and promises.
J Hepatol. 2013 Nov;59(5):1124-6. |
28. | Marschall HU, Krawczyk M, Grünhage F, Katsika D, Einarsson C, Lammert F.
Gallstone disease in Swedish twins is associated with the Gilbert variant of UGT1A1.
Liver Int. 2013 Jul;33(6):904-8. |
29. | Ney JT, Juhasz-Boess I, Gruenhage F, Graeber S, Bohle RM, Pfreundschuh M, Solomayer EF, Assmann G.
Genetic polymorphism of the OPG gene associated with breast cancer.
BMC Cancer. 2013 Jan 31;13:40 |
30. | Nischalke HD, Berger C, Lutz P, Langhans B, Wolter F, Eisenhardt M, Krämer B, Kokordelis P, Glässner A, Müller T, Rosendahl J, Fischer J, Berg T, Grünhage F, Leifeld L, Soyka M, Nattermann J, Sauerbruch T, Stickel F, Spengler U.
Influence of the CXCL1 rs4074 A allele on alcohol induced cirrhosis and HCC in patients of European descent.
PLoS One. 2013 Nov 18;8(11):e80848. |
31. | Obeid R, Jung J, Falk J, Herrmann W, Geisel J, Friesenhahn-Ochs B, Lammert F, Fassbender K, Kostopoulos P.
Serum vitamin B12 not reflecting vitamin B12 status in patients with type 2 diabetes.
Biochimie. 2013 May;95(5):1056-61. |
32. | Pieper-Fürst U, Lammert F.
Low-density lipoprotein receptors in liver: old acquaintances and a newcomer.
Biochim Biophys Acta. 2013 Jul;1831(7):1191-8. |
33. | Reiberger T, Ferlitsch A, Payer BA, Mandorfer M, Heinisch BB, Hayden H, Lammert F, Trauner M, Peck-Radosavljevic M, Vogelsang H.
Nonselective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
J Hepatol. 2012 Dec 19. pii: S0168-8278(12)00959-2. doi: 10.1016/j.jhep.2012.12.011. [Epub ahead of print] |
34. | Roop RP, Naughton MJ, Van Poznak C, Schneider JG, Lammers PE, Pluard TJ, Johnson F, Eby CS, Weilbaecher KN.
A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.
Clin Breast Cancer. 2013 Dec;13(6):409-15. |
35. | Sauerbruch T, Appenrodt B, Schmitz V, Spengler U.
The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis.
Dtsch Arztebl Int. 2013 Feb;110(8):126-32, |
36. | Schirmer SH, Kiefer M, Kim YJ, Schneider G, Schäfers HJ, Zimmer V.
Secondary Budd-Chiari syndrome complicating calcified right atrial thrombosis related to ventriculoatrial shunt.
Clin Res Cardiol. 2013 Feb;102(2):165-8 |
37. | Schmelzle M, Splith K, Andersen LW, Kornek M, Schuppan D, Jones-Bamman C, Nowak M, Toxavidis V, Salhanick SD, Han L, Schulte am Esch J, Jonas S, Donnino MW, Robson SC.
Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury.
Transplantation. 2013 Jan 15;95(1):63-9. |
38. | Schöfl C, Franz H, Grussendorf M, Honegger J, Jaursch-Hancke C, Mayr B, Schopohl J; participants of the German Acromegaly Register.
Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register.
Eur J Endocrinol. 2012 Dec 10;168(1):39-47. |
39. | Schughart K, Libert C; SYSGENET consortium, Kas MJ.
Controlling complexity: the clinical relevance of mouse complex genetics.
Eur J Hum Genet. 2013 Nov;21(11):1191-6. |
40. | Seiler F, Hellberg J, Lepper PM, Kamyschnikow A, Herr C, Bischoff M, Langer F, Schäfers HJ, Lammert F, Menger MD, Bals R, Beisswenger C.
FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells.
J Immunol. 2013 Feb 15;190(4):1603-13 |
41. | Stokes CS, Volmer DA, Grünhage F, Lammert F.
Vitamin D in chronic liver disease.
Liver Int. 2013 Mar;33(3):338-52. |
42. | von Kampen O, Buch S, Nothnagel M, Azocar L, Molina H, Brosch M, Erhart W, von Schönfels W, Egberts J, Seeger M, Arlt A, Balschun T, Franke A, Lerch MM, Mayerle J, Kratzer W, Boehm BO, Huse K, Schniewind B, Tiemann K, Jiang ZY, Han TQ, Mittal B, Srivastava A, Fenger M, Jørgensen T, Schirin-Sokhan R, Tönjes A, Wittenburg H, Stumvoll M, Kalthoff H, Lammert F, Tepel J, Puschel K, Becker T, Schreiber S, Platzer M, Völzke H, Krawczak M, Miquel JF, Schafmayer C, Hampe J.
Genetic and functional identification of the likely causative variant for cholesterol gallstone disease at the ABCG5/8 lithogenic locus.
Hepatology. 2013 Jun;57(6):2407-17. |
43. | Weng HL, Feng DC, Radaeva S, Kong XN, Wang L, Liu Y, Li Q, Shen H, Gao YP, Müllenbach R, Munker S, Huang T, Chen JL, Zimmer V, Lammert F, Mertens PR, Cai WM, Dooley S, Gao B.
IFN-γ inhibits liver progenitor cell proliferation in HBV-infected patients and in 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet-fed mice.
J Hepatol. 2013 Oct;59(4):738-45. |
44. | Wolska-Krawczyk M, Krawczyk M, Katoh M, Grünhage F, Schmitt K, Bohle RM, Lammert F, Buecker A.
Liver fibrosis: how many samples in transjugular liver biopsy are sufficient? Histological vs. clinical value.
Abdom Imaging. 2013 Jun;38(3):461-4. |
45. | Yoshida S, Kornek M, Ikenaga N, Schmelzle M, Masuzaki R, Csizmadia E, Wu Y, Robson SC, Schuppan D.
Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma.
Hepatology. 2013 Nov;58(5):1667-80. |
46. | Zimmer V, Rohrer T, Lammert F.
Ein "diagnostisches" Mosaik
MMW Fortschr Med. 2013 Oct 24;155(18):5. |
47. | Zimmer V, Lammert F.
67-jähriger Patient mit rezidivierenden gastroduodenalen Ulzera
Dtsch Med Wochenschr. 2013 May;138(22):1163-4. |
48. | Zimmer V, Massmann A, Lammert F.
Clinical genetics in endoscopy: a two-question diagnosis in a patient with gastrointestinal angiodysplasia.
Dig Endosc. 2013 Mar;25(2):207-8. |
